Source link : https://newshealth.biz/health-news/selumetinib-shrinks-nf1-plexiform-neurofibromas-in-adults-too/
(MedPage Today) — CHICAGO — Selumetinib (Koselugo) significantly improved response rates in adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas, the phase III KOMET trial showed. After 16 cycles… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115874 Author : Publish date : 2025-06-03 15:43:00 Copyright for syndicated content belongs to the linked Source.
The post Selumetinib Shrinks NF1-Plexiform Neurofibromas in Adults, Too first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-03 15:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8